Consolidated Financial Statements under ind AS Consolidated Statement of Cash Flows (in mitions excopt snare and por crave gata, unloes othowuce ettod) Fortheyearended Fortheyear ended Maren 31,2026 March 31, 2023 Cash flows from financing activities: Proceeds from issuance of equity shares and shares pending allotment 13 2 Repayment of borrowings (30.557) (188,910) Proceeds rom borrowings ___ 120,500 161,036 Payment of esse lisbiliies (10,080) ea) Payment for contingent consideration ___01.294) (1,784) Interest and finance costs paid (10,456) (8,708) Payment of dividend (5218) 22814) Payment of dividend to non-cantvalling interests holders Payment for buyback of equity shares, including taxand transaction cost [Not cash used in financing activities (182,567) (60,881) [Net inerease/decransa) in cash and cash equualents during the year 5329 (14,345) Effect of axchango rate changos on cash and eash equvalonts (239) 2378 Cash and cash equivalents at the beginning ofthe year 91,861 103,833, Cash and cash equivalents at the ond of the yoar (Refer to Note 15) 96,051 91,861 Refer to Note 17 for supplementary information on consolidated statement of cash flows The accompanying notes form an integral part of these consolidated financial statements: As per our report of even date attached For and on behalf of the Board of Directors For Deloitte Haskins & Sells LLP Rishad A. Premji DeepakM.Satwalekar Srinivas Pallia Chartered Accountants Chairman Director Chiet Executive Officer Firms Registration No. 117366W/W- 100018 —_(DIN-02983899) {DIN:00009627) and Managing Director (IN: 10574442) Anand Subramanian ‘Aparna C.tyer M.Sanaulla Khan Partner Chief Financiat Officer Company Secretary Membership No.:110815 Bengaluru May 22,2024 262 Ambitions RealizedConsolidated Financial Statements under ind AS. Consolidated Balance Sheet inmilions,oxcept share and per share data, unless otherwise stated) Notes aren 2084 __Marchat.2003 GABIITIES Non-currentiabitties Financial abies Borrowings ” 2,300 Lease abies 57 19,962 Derivative bites 10 ‘ Other nancial abies 18 ‘908 Provisions 19 4.210 Deterred tax labities net) 2 17467 Non-curent ax abilities (net) 37,090 Other non-current ailties 20 8751 Total non-currentUablities 148,778 Currant tables Financial laiities Borrowings ” 72,166 e921 Lease Ualites 5:7 221 2,620 Derivative abies 10 558 2925 Trade payables n 57,955 59,723 Other financial abies 8 33,108 33472 Contratabtties 17,658 ne82 Other current abiities 20 15,238 14390 Provisions 19 1,028 16,436 Currentta bits (red) 21,756 19,066 Total current labilties 252.458 207,783 TOTAL UABILES 101206 394,060 TOTAL EQUITY AND LIABILITIES 147,908 4,971,897 The accompanying notes form an integral part ofthese consol dated nancial statements ‘sper our report of even date attached For andon behalf ofthe Board of Dectors For Deloitte Haskins & Sells LLP Rishad A Prom DeopakM.Satwatekar Srinivas Palla Chartered Accountants Chairman Director Chief Executive Officer Firmis Registration No: 117366W/W- 100018 (DIN: 02983809) (OW: 00000627 and Managing Dector (OWN: 10574442) ‘Anand Subramanian Apamac.yer M.Sanautla Khan Partner Chit Financia Officer Company Secretary Membership No.:110815 Bengaluru May 22,2024 aValve Creation for Stakeholders Risk Management ‘Statutory Reports and Financial Statements Consolidated Financial Statements under nd AS Consolidated Statement of Cash Flows (Rin mitions, xcept share and por share data, unless ctharwise stated) Forthe year ended Forthe year ended March32024 "March, 2083 ‘Gash flows from operating activities Profit for the year ana 113,665, ‘Adjustments to reconeile profit for the year to net cash generated from operating activities . Gainon sae of property plant and equipment, net (or 89) Depreciation, smertisation and imparment expense asa71 33.402 Unreaised exchange (gninVlos, net and exchange gain on borrowings 65s 152 Share-based compensation expense 5,584 3,969 Shareot net (profitvlows of associates accounted for using eauty method 29 37 Income taxorpenae 36,088 33,992 Finance and other income. net of inance costs (1,340) (2,108) Change in far value of contingent cons eration (1,300) er) (Gain/1os8 from sale of business ang investment accounted fr using the equity methoo : 6 Other non-cash items 43 : Changes in operating assets and liabilities, netof effects from acquisitions ee Trade receivables 8,464 (985) Unbilled receivables and contract assets san9 1,558 Inventories 287 162 ther assets 8,069 1.055 Trade payables, other liabites and provisions ss) (9.824) Contract liabilities (6,053) (6.522) Cash generated from operating activites before taxes 101,576 160,818 income teres paid. net (18.360) (0218) Net cash generated from operating activities 176216 130,601 Cash lows from investing activi Payment fr purchase of property pian and equipment (0510) (04,890) Proveeds from disposal af eropety pant and equioment ze 566 Payment fr purchase of investments (075,060) (206,62) Proceeds from sale investments 978,598 740,885 Proceeds trom restricted interim dvdend aceount 27410 Payment for business acquisitions including daposits and escrow, net of cash acquired (5,291) (45,566) Payment for investment in joint venture 40) = Proceeds from sale of business net of cash : " Proceeds from securty depos for property plant ard equipment 300 3 Interest received 20411 1412 Owidend received a a Net cash generated from/used i) investing activities (66,065) Integrated Annual Report 2023: 261Consolidated Financial Statements under Ind AS Consolidated Balance Sheet (@inmilions, except share and per share data, unless otherwise stat Noten arch 31026 Maren3t,2023 ASSETS Non-current assets Property. plant and equipment 4 14.128 82,336 Right-of-Use assets 5 18,702 Capital work-in-progress 6 7,238 8,71 Gooditt 7 311,448 303,485, Other intangible assets 7 32,748 43,045 Investments accounted for using the equity method 9 1,046 780 Financial assets : Investments 9 21,629 20,720 Derivative assets 10 28 29 ‘Trade receivables " 4,065 63 Other fnancialassets R 5,550 6,330 Deferred tax assets (net) 2B 1.817 2.400 Non-current tax assets (net) 9,043 11,922 Other non-current assets, 3 10,577 Total non-current assets 497,266 510,26 Current assets Inventories 1% 907 4,188 Financial assets i. , Investments 8 3na71 309.232 Derwative assets 10 1,333 1,844 Trade receivables " 1847 126,350 Unbitled receivables 88,365 60515 Cash and cash equivalents 15 96,959 91,880 Other financialassets 2 10,536 9,096 Current tax assets (net) 6,486 5,091 Contract assets 10,854 23,001 Other current assets 3 29,602 32,899 ‘Total current assets (550,662 661,096, ‘TOTAL ASSETS 1.147.906 4,971,337 EQUITY AND LIABILITIES EQUITY Equity share capital 16 10,450 10.878 Other equity 734,880 765,703, Equity attributable to the equity holders of the Company 745,330 778,678 Non-controlling interests 1.340 589 ‘TOTAL EQUITY 746,670 777.268, Integrated Annual Report 2023-24 255Consolidated Financial Statements under Ind AS Consolidated Statement of Profit and Loss (€inmiltors, expt share and per shara data, unless otherwise stated) vom |S ant rosa raat oa wit ag — ee See cortege a ee ss km er ate ie Teatnpe waa mrs Profit before share of net profit/(loss) of associate and joint venture 147.443 147.714 ees a aia ott a at watt eT ii iat a ‘Other Comprehensive Income (OCI) Ponca near eines arian : ee mca romero cn _ tems that wilt! - _ Net change in time value of option contracts designated as cash flow hedges 10 258 (238) ‘Total other comprehensive income for the year, net of taxes Total comprehensive Income for the year Integrated Annual Report 2023-24 287Consolidated Financial Statements under Ind AS Consolidated Statement of Profit and Loss [in milions, except share and por share data, unless otherwise stated) tien Year ended Yoarendes March31, 2026 March31, 2023 Profitfor the year attributable t Equity holders of the Company, 110,452 118,500 Non-contralling interests 669 165 104,121 113, ‘Total comprehensive income for the year attributable to: Equity holders of the Company, 1178678 124,186 Non-controling interests, 504 27 118,180 126,403 Earnings per equity share: (Equity shares of par value 2 each) 30 Basic 20.89 20.73 Diluted 20.82 20.68 Weighted average number of equity shares used in computing earnings per equity share Basic Diluted The accompanying nates form an integral part of thase consolidated financial statements 5,288,285,555 _§,477,466,573 5,305,712,314 5,488,991,175 ‘As per our report of even date attached For and on behalf of the Board of Directors For Deloitte Haskins & Sells LLP Rishad A. Premji DeopakM.Satwalekar Srinivas Pallia Chartered Accountants Chairman Director Chief Executive Officer Firm's Registration No.:117366W/W- 100018 (DIN: 02983899) (1N:00009627) and Managing Director (DIN: 10874442) ‘Anand Subramanian ‘Aparna C. yer M.Sanaulla Khan Partner, Chief Financial Officer Company Secretary Membership No.:110815, Bengaluru May 22,2024